Statistics
Publications
36
Citations
3.1K
H-Index
25
Active since
1999
Fangyi Zhao is an author at Eli Lilly (United States) specializing in pharmacotherapy, medicine, and psychopharmacology.
Publications per year
1999–2025
36
36
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Kenneth B. Gordon, Andrew Blauvelt, Kim Papp et al. · New England Journal of Medicine · 2016 · 838 citations · Full text
Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados et al. · The Lancet · 2018 · 359 citations · Full text
Dantrolene Inhibition of Ryanodine Receptor Ca2+Release Channels
Fangyi Zhao, Pin Li, S. R. Wayne Chen et al. · Journal of Biological Chemistry · 2001 · 323 citations · Full text
Atul Deodhar, Denis Poddubnyy, César Pacheco‐Tena et al. · Arthritis & Rheumatology · 2018 · 233 citations · Full text
1–5 of 36